Inventor · disambiguated record
Zhijie Liu
Also filed as: LIU ZHIJIE
10 granted patents·7 pending applications·44 citations·filing 2016–2024
85Inventor score
Files withJANSSEN PHARMACEUTICA NV9VITAE PHARMACEUTICALS LLC3ACTELION PHARMACEUTICALS LTD2VITAE PHARMACEUTICALS INC2UNIV SHANGHAI TECHNOLOGY1
Top patents by PatentIndex Score
17 records- 0194US10047085B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·14 cites·20 claims
- 0294US9624217B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·14 cites·22 claims
- 0393US10399976B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Sep 3, 2019·11 cites·20 claims
- 0487US10807980B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Oct 20, 2020·4 cites·20 claims
- 0586US11535614B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 0673US2024228465A1Substituted pyridine n-oxide derivatives useful as a factor xia inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0767US11919881B2Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Mar 5, 2024·0 cites·9 claims
- 0862US2023295157A13-(1h-imidazol-2-yl)-2,3,8,8a-tetrahydroindolizin-5(1h)-one derivatives useful as factor xia inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0962US2025163065A1Pyrrolotriazinone compound, pharmaceutical composition comprising same, preparation method therefor, and use thereofUNIV SHANGHAI TECHNOLOGY·Filed 2023·Application pending·0 cites
- 1061US11897880B27,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Feb 13, 2024·0 cites·11 claims
- 1160US11958856B2Substituted 1,2,3,8,9,9a-hexahydro-5H-pyrrolo[1,2-a]azepin-5-ones as factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Apr 16, 2024·0 cites·16 claims
- 1259US11845748B2Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Dec 19, 2023·0 cites·10 claims
- 1359US2024360134A1Pyrazolopyrimidines and their uses as pdgfr inhibitorsACTELION PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1459US2023183233A1Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1558US2023097157A1Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1656US2024109917A1Pyrazolothiazole carboxamides and their uses as pdgfr inhibitorsACTELION PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1755US11814364B2Pyridine N-oxide derivatives useful as factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 14, 2023·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Zhijie Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →